Validation of the Brief Fear of Negative Evaluation Scale ‐II in patients with systemic sclerosis: A Scleroderma Patient‐centered Intervention Network Cohort study

ConclusionPsychometric support was found for all three versions of the BFNE, though the longer 12‐item BFNE‐II did not improve measurement compared to the shorter eight‐item versions. Of these two, the BFNE‐S has been more widely studied with strong validity data in a greater number of populations. Therefore, the BFNE‐S is recommended to assess fear of negative evaluation among patients with SSc.This article is protected by copyright. All rights reserved.

Source: Arthritis Care and Research - February 6, 2018 Category: Rheumatology Authors: Rina S. Fox, Linda Kwakkenbos, Marie ‐Eve Carrier, Sarah D. Mills, Shadi Gholizadeh, Lisa R. Jewett, Scott C. Roesch, Erin L. Merz, Shervin Assassi, Daniel E Furst, Karen Gottesman, Maureen D. Mayes, Brett D. Thombs, Vanessa L. Malcarne, Tags: Original Article Source Type: research